 |
|
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu
Clin Mol Hepatol. 2021;27(1):186-196. Published online 2020 Dec 3 DOI: https://doi.org/10.3350/cmh.2020.0180
|
|
Citations to this article as recorded by
 Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Je
Clinical and Molecular Hepatology.2024; 30(3): 468. CrossRef Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review
Chen-Hua Liu, Yu-Ping Chang, Jia-Horng Kao
Expert Opinion on Pharmacotherapy.2024; 25(12): 1691. CrossRef Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study
Takeya Tsutsumi, Hiroshi Yotsuyanagi
Kanzo.2024; 65(8): 368. CrossRef Enhancing hepatitis C management in ESRD: Evaluating efficacy and safety of alternative antiviral regimens
Ume Aiman, Umer Bin Shahzad
Therapeutic Apheresis and Dialysis.2024; 28(6): 967. CrossRef Predictive value of osteoprotegerin and heart fatty acid binding protein as biomarkers for heart failure in chronic kidney disease patients on hemodialysis: A case-control study
Saddam Jaber Khudiar, Rayah Sulaiman Baban, Arif Sami Malik
Journal of Research in Pharmacy.2024; 29(2): 682. CrossRef TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes
Ming-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, Horng-Yih Ou, Pin-Nan Cheng, Shih-Te Tu, Jee-Fu Huang, Jung-Fu Chen, Tsung-Hui Hu, Chih-Cheng Hsu, Jia-Horng Kao, Chien-Jen Chen, Han-Chieh Lin, Chien-Ning Huang
Journal of the Formosan Medical Association.2023; 122(3): 202. CrossRef Drug–Drug Interactions With Over-The-Counter Medicines: Mind the Unprescribed
Oliver Scherf-Clavel
Therapeutic Drug Monitoring.2022; 44(2): 253. CrossRef Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
Chen-Hua Liu, Jia-Horng Kao
Hepatology International.2022; 16(5): 1001. CrossRef Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Mario Enrico Canonico, Giuseppe Damiano Sanna, Roberta Siciliano, Fernando Scudiero, Giovanni Esposito, Guido Parodi
Frontiers in Pharmacology.2022;[Epub] CrossRef Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid‐Reducing Agents
Tyler Shugg, Nicholas R. Powell, Patrick J. Marroum, Todd C. Skaar, Islam R. Younis
Clinical Pharmacology & Therapeutics.2022; 112(5): 1088. CrossRef Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
Vicki Wing-Ki Hui, Christopher Langjun Au, Amy Shuk Man Lam, Terry Cheuk-Fung Yip, Yee-Kit Tse, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
Hepatology International.2022; 16(6): 1318. CrossRef HCV GT1b-patient With Alanine Aminotransferase Elevation and Sustained Virologic Response Achieved By grazoprevir/elbasvir Discontinuation
Hiroshi Takahashi, Tatsuo Kanda, Naoki Matsumoto, Taku Mizutani, Tomohiro Kaneko, Masayuki Honda, Yoichiro Yamana, Tomotaka Ishii, Mariko Kumagawa, Reina Sasaki, Ryota Masuzaki, Kazushige Nirei, Hiroaki Yamagami, Masahiro Ogawa, Shunichi Matsuoka, Mitsuhi
Future Virology.2021; 16(3): 161. CrossRef Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir/velpatasvir therapy
Chung-Feng Huang, Yu-Ju Wei, Yu-Tse Wu, Yi-Wen Chiu, Ming-Lung Yu
Journal of Hepatology.2021; 75(4): 1006. CrossRef
|